Search clinical trials for: Recurrent Pregnancy Loss

Total 72182 results

University Hospital Tuebingen

Recruiting

Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer (ProSperACC-1)

Prostate Cancer Recurrent

Germany
john eisenbrey
National Cancer Institute (NCI)

Recruiting

Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation

Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma

United States
Imperial College London
Cancer Research UK

Recruiting

A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia

Gestational Trophoblastic Neoplasia | Gestational Trophoblastic Disease | Gestational Trophoblastic Tumor, Recurrent

United Kingdom
Women's Hospital School Of Medicine Zhejiang University

Not yet recruiting

Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer

Cytoreductive Surgery

China
Fundacin Biomedica Galicia Sur
University of Vigo; Galician South Health Research Institute

Not yet recruiting

Differential Diagnosis of Persistent COVID-19 by Artificial Intelligence (DICOPERIA)

COVID-19 | Fatigue | Cognitive Dysfunction | COVID-19 Recurrent | SARS CoV 2 Infection | Distress Respiratory Syndrome

Spain
Christian Mølgaard
University of Copenhagen; Dept. of Obstetrics and Gynecology, Hvidovre Hospital... and other collaborators

Recruiting

PRE-Pregnancy Weight Loss And the Reducing Effect on CHILDhood Overweight - Copenhagen (PREPARE CHILD)

Weight Loss | Pregnancy Related | Overweight and Obesity

Denmark
Imam Abdulrahman Bin Faisal University

Recruiting

Effect of Bio-electromagnetic Energy Regulation Therapy on Erectile Dysfunction in Patients With Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting | Erectile Dysfunction Due to Diseases Classified Elsewhere

Saudi Arabia
Karyopharm Therapeutics Inc
GOG Foundation; European Network of Gynaecological Oncological Trial Groups... and other collaborators

Recruiting

Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma (XPORT-EC-042)

Endometrial Cancer

United States, Belgium, Spain, Israel, Australia, Italy, Georgia, Ireland, Greece, Germany, Czechia, Slovakia, Canada, Hungary
Sham Sunder Kakar
University of Louisville Health Care

Recruiting

Combination Therapy for Recurrent Ovarian Cancer

Recurrent Ovarian Cancer

United States
Health Science Center of Xi'an Jiaotong University

Recruiting

Efficacy and Safety of Caldonirimab Plus Nimotuzumab for Recurrent or Metastatic Cervical Cancer (GCR-05)

Cervical Cancer

China
Aaron Wolfson

Recruiting

Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma

Recurrent Endometrial Carcinoma | Unresectable Endometrial Carcinoma

United States
VA Office of Research and Development

Recruiting

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss (SNARE)

High-Risk Prostate Cancer

United States
Aalborg University Hospital
Aalborg University

Recruiting

Bacterial Composition and Recurrent Cystitis in Postmenopausal Women After Treatment With Lactobacilli.

Lactobacillus Infection | Cystitis Recurrent

Denmark
National Cancer Institute (NCI)

Recruiting

Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

Prostate Cancer | Biochemically Recurrent

United States
Sohag University

Not yet recruiting

Cyclosporine Adverse Outcomes in Steroid Dependent and Frequent Relapsing Nephrotic Syndrome in Children;Single Center Study

Steroid Dependent and Frequent Relapsing Nephrotic Syndrome

Egypt
Vaginal Biome Science
ChristianaCare

Recruiting

Vaginal Care System for Menopausal Women With Urinary Tract Infections

Urinary Tract Infections | Vaginal Flora Imbalance

United States
Verismo Therapeutics

Recruiting

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

Ovarian Cancer | Mesothelioma, Malignant | Cholangiocarcinoma Recurrent

United States
National Cancer Institute (NCI)

Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Anatomic Stage III Breast Cancer AJCC v8 | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid... and other conditions

United States, Puerto Rico
University of Alabama at Birmingham

Recruiting

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

Carcinoma | Gynecologic Cancer | Endometrial Cancer | Uterine Cancer

United States
Shanghai Pudong Hospital

Recruiting

An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer

Recurrent or Metastatic Bladder Cancer

China
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Cohort of Patients Presenting Unexplained Recurrent Miscarriages and Identification of Early Miscarriage Recidivism Factors (FALCO)

Miscarriage

France
The Netherlands Cancer Institute

Recruiting

Tracer-Guided Surgery for Recurrent Prostate Cancer (Trace-II)

Prostate Cancer

Netherlands
National Cancer Institute (NCI)
NRG Oncology

Recruiting

Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Carcinoma

United States, Puerto Rico
Hvidovre University Hospital

Recruiting

The Effect of ASTARTE™ on Recurrent Urinary Tract Infection (rUTI)

Recurrent Urinary Tract Infection

Denmark
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Not yet recruiting

Camrelizumab Plus Anlotinib in Patients With Recurrent Sporadic MMRd Endometrial Cancer (CAN-RESPOND)

Endometrial Cancer
Chongqing University Cancer Hospital

Recruiting

Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi

Ovarian Cancer

China
Technical University of Munich
School of Medicine, Technical University Munich, Münchner Studienzentrum; Klinikum...

Recruiting

Individualized Homeopathy to Reduce the Use of Antibiotics in Women With Recurrent Uncomplicated Urinary Tract Infections (iHOM)

Urinary Tract Infection Chronic

Germany
National Cancer Institute (NCI)
NRG Oncology

Recruiting

Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers

Recurrent Endometrial Endometrioid Adenocarcinoma | Stage IV Uterine Corpus Cancer AJCC v8 | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | Metastatic Endometrial Endometrioid Adenocarcinoma

United States
OZORI EBIOGBO STANLEY

Recruiting

Sublingual Misoprostol in Reduction of Caesarean Blood Loss (SUMIROCBLOL)

Post Partum Hemorrhage

Nigeria
Boston Children's Hospital

Recruiting

Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome

Genetic Disease | Chopra-Amiel-Gordon Syndrome | CAGS | ANKRD17

United States
Bayer

Recruiting

A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide (ARAMON)

Biochemically Recurrent Prostate Cancer

United States
ImmunoGen, Inc.

Recruiting

First in Human Study of IMGN151 in Recurrent Endometrial Cancer and Recurrent, High-grade Serous Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers

Fallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal Carcinoma | High Grade Serous Adenocarcinoma of Ovary

United States
University of Oklahoma
GlaxoSmithKline

Recruiting

Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation (ARID1A)

Recurrent Ovarian Carcinoma | Recurrent Endometrial Carcinoma | ARID1A Gene Mutation

United States
National Cancer Institute (NCI)

Not yet recruiting

Study to Determine Possible Effects of Apalutamide on EGFR Expression in Patients With Non-muscle Invasive Bladder Cancer

Non-Muscle Invasive Bladder Urothelial Carcinoma | Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma

United States
Tripler Army Medical Center

Recruiting

Weight Loss and Physical Fitness Following Pregnancy in Active Duty Women (PADaWL)

Weight Loss | Postpartum Weight Retention

United States
Compass Therapeutics

Recruiting

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

Cholangiocarcinoma | Biliary Tract Cancer | Gall Bladder Cancer | Ampullary Cancer

United States
University of Chicago
Lucile Packard Children's Hospital

Not yet recruiting

Oxytocin Pharmacokinetics and Pharmacodynamics

Blood Loss | Cesarean Section Complications | Post Partum Hemorrhage

United States
Peking University Third Hospital

Not yet recruiting

Cesarean Scar Pregnancy and Clinical Outcomes

Blood Loss | Placenta Accreta Spectrum | Hysterectomy | Abortion | Repeat Cesarean Section | Maternal Transmission
Maastricht University Medical Center

Recruiting

Protein and Exercise Training in Chronic KIDNEY Disease (PET KIDNEY)

Kidney Diseases | Muscle Loss

Netherlands
Zin W Myint
ArtemiLife

Recruiting

ArtemiCoffee in Patients With Rising PSA

Prostate Cancer

United States
Stephanie Wang Zuo

Recruiting

Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections (TAPER)

Recurrent Urinary Tract Infection

United States
Haider Mahdi
Merck Sharp & Dohme LLC; ALX Oncology

Recruiting

Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer

Ovarian Cancer

United States
Yonsei University

Recruiting

Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation.

Ovarian Cancer

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Recruiting

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

METASTATIC CERVICAL CANCER

China
ImmunoGen, Inc.
GOG Foundation

Recruiting

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA)

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

United States, Korea, Republic of, Spain, Australia, Canada, United Kingdom, Italy, Czechia, Philippines, Israel, Belgium
Sichuan Cancer Hospital and Research Institute

Not yet recruiting

A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer

Cervical Cancer

China
Yonsei University

Recruiting

Salvage Systemic Therapy With or Without Stereotactic Ablative Radiotherapy for Recurrent Ovarian Cancer (SABR-ROC)

Recurrent Epithelial Ovarian Cancer

Korea, Republic of
Zhongda Hospital

Not yet recruiting

Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer

Ovarian Cancer, Epithelial

China
Ohio State University Comprehensive Cancer Center

Recruiting

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer

Ovarian Endometrioid Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous Adenocarcinoma | Fallopian Tube Serous Adenocarcinoma | Ovarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Primary Peritoneal Endometrioid... and other conditions

United States
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors

Stage IV Ovarian Cancer | Endometrial Cancer Recurrent | Testis Cancer, Refractory | CAR NK

China

Search clinical trials for: Recurrent Pregnancy Loss

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations